7-107675112-A-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000441.2(SLC26A4):c.765+3A>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000441.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461280Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726968
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Pendred syndrome Pathogenic:1
Variant summary: SLC26A4 c.765+3A>T alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. Several computational tools predict a significant impact on normal splicing: Three predict the variant abolishes a canonical 5' splicing donor site and one predicts it weakens the 5' donor site. At least two publications report experimental evidence that this variant indeed affects mRNA splicing, causing the skipping of exon 6, which is predicted to result in an in-frame deletion of the exon. The variant was absent in 251098 control chromosomes (gnomAD). c.765+3A>T has been reported in the literature in the compound heterozygous state in an individual affected with Pendred Syndrome (Rendtorff_2013) and in the heterozygous state in a pair of siblings with early-onset non-syndromic hearing loss (Hutchin_2005). One clinical diagnostic laboratory has submitted a clinical-significance assessment for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
This variant is not present in population databases (ExAC no frequency). This sequence change falls in intron 6 of the SLC26A4 gene. It does not directly change the encoded amino acid sequence of the SLC26A4 protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. This variant has been observed in individual(s) with clinical features of SLC26A4-related conditions (PMID: 16283880, 23336812). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as IVS6+3A>T. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 6, but is expected to preserve the integrity of the reading-frame (PMID: 23336812). This variant disrupts a region of the SLC26A4 protein in which other variant(s) (p.Gln235Arg) have been determined to be pathogenic (PMID: 9618166, 10861298, 12354788, 15689455, 22717225). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at